Clinical Trial Update: Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on a phase 2/3 study using EBV DNA-guided, individualized treatment for stage II-IVB nasopharyngeal carcinoma; the trial is currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: NRG Oncology | Conditions: Epstein-Barr Virus Infection, Stage II Nasopharyngeal Carcinoma | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING